XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation, Stock Option Activity (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Common Stock [Member]            
Number of Shares [Roll Forward]            
Exercised (in shares) (1,409) (7,794) (2,282)      
Unamortized Stock Compensation Expense [Abstract]            
Shares issued for consulting services (in shares) 100,000     100,000    
Stock Options [Member]            
Number of Shares [Roll Forward]            
Options outstanding, beginning balance (in shares)       4,171,311    
Granted (in shares) 29,900 494,000   1,154,500 1,439,005  
Exercised (in shares)       (1,409)    
Forfeited and expired (in shares)       0    
Options outstanding, ending balance (in shares) 5,324,402     5,324,402   4,171,311
Vested and expected to vest (in shares) 5,324,402     5,324,402    
Exercisable (in shares) 2,513,595     2,513,595    
Weighted Average Exercise Price [Roll Forward]            
Options outstanding, beginning balance (in dollars per share)       $ 5.56    
Granted (in dollars per share)       11.45    
Exercised (in dollars per share)       0    
Forfeited and expired (in dollars per share)       0    
Options outstanding, ending balance (in dollars per share) $ 6.85     6.85   $ 5.56
Vested and expected to vest (in dollars per share) 6.85     6.85    
Exercisable (in dollars per share) $ 5.8     $ 5.8    
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value [Abstract]            
Options outstanding, weighted average remaining contractual life       7 years 10 months 9 days   7 years 10 months 20 days
Vested and expected to vest, weighted average remaining contractual life       7 years 10 months 9 days    
Exercisable, weighted average remaining contractual life       6 years 9 months 29 days    
Options outstanding, aggregate intrinsic value       $ 10,839,589    
Options outstanding, aggregate intrinsic value $ 4,645,635     4,645,635   $ 10,839,589
Vested and expected to vest, aggregate intrinsic value 4,645,635     4,645,635    
Exercisable, aggregate intrinsic value 2,901,233     2,901,233    
Unamortized Stock Compensation Expense [Abstract]            
Unamortized stock compensation expense $ 20,357,890     $ 20,357,890    
Period for recognition       2 years 9 months